Cardiovascular Medicine

9 pages, 349 KB

Open AccessArticle

Interventional Cardiology in Switzerland During the Year 2005

by Micha T. Maeder, Jean-Christoph Stauffer, Stephan Windecker, Giovanni Pedrazzini, André Vuillomenet and Hans Rickli

Cardiovasc. Med. 2007, 10(3), 92; https://doi.org/10.4414/cvm.2007.01233 - 23 Mar 2007

Cited by 1 | Viewed by 11

Abstract

Background: Since 1987, a nationwide annual survey of percutaneous cardiac interventions is performed in Switzerland, which allows recognition of contemporary trends and comparison with other countries. Methods: Based on a standardised questionnaire, all adult percutaneous cardiac intervention centres in Switzerland were asked to report on the volume and the circumstances of their activities in 2005. The response rate was 100%. Data were compared with those from previous years. Results: In 2005, 36 436 coronary angiographies (CA) (2004: 35 201; + 3.5%) and 16 624 percutaneous coronary interventions (PCI) (2004: 15 680; + 6%) were carried out in 5 university hospitals, 9 public, non-university hospitals, and 13 private hospitals by 205 operators (80 of them performing only diagnostic studies). Ninety-three percent of PCI were performed ad hoc, and 78% were single-vessel interventions. Stents were placed in 91% of PCI (2004: 91%). Drug-eluting stents (DES) were used in 78% of procedures (2004: 66%). Emergency procedures (primary PCI or rescue PCI after failed thrombolysis) accounted for 19% of interventions. Glycoprotein IIb/IIIa inhibitors were used in 23% of PCI (2004: 23%). Myocardial infarction after PCI was reported in 1.1% of PCI, emergency coronary artery bypass grafting was needed in 0.1% of cases, and in-hospital mortality after PCI was 0.5%. In addition, 52 mitral, 11 aortic, and 16 pulmonary balloon valvuloplasties, and 510 interventions for closure of patent foramen ovale (2004: 438) as well as 94 interventions for closure of atrial septal defect (2004: 92) were performed. Conclusions: The number of CA and PCI and especially the utilisation of DES are steadily increasing in Switzerland. The number of interventions for closure of patent foramen ovale and atrial septal defect is still growing, most probably due to a more aggressive diagnostic work-up and treatment of patients with stroke. Full article

5 pages, 174 KB

Open AccessEditorial

Interventional Cardiology on a Roll

by Bernhard Meier

Cardiovasc. Med. 2007, 10(3), 87; https://doi.org/10.4414/cvm.2007.01237 - 23 Mar 2007

Viewed by 7

Abstract

The year 2007 marks the 30th anniversary of percutaneous transluminal coronary angioplasty (PTCA), more recently called percutaneous coronary intervention (PCI) [...] Full article

2 pages, 362 KB

Open AccessInteresting Images

Myocardial Perfusion SPECT Features of Severe Pulmonary Artery Hypertension

by Micha T. Maeder, Martin Stöckli and Michael J. Zellweger

Cardiovasc. Med. 2007, 10(3), 113; https://doi.org/10.4414/cvm.2007.01234 (registering DOI) - 23 Mar 2007

Cited by 1 | Viewed by 16

Abstract

A 49-year-old man with a history of sarcoidosis and associated severe pulmonary hypertension was referred for myocardial perfusion imaging (MPI) because of preoperative workup (planed lung transplant) [...] Full article

2 pages, 180 KB

Open AccessInteresting Images

Progrediente Herzinsuffizienz Trotz Biventrikulärer Stimulation

by C. Bösch, B. Schaer and S. Osswald

Cardiovasc. Med. 2007, 10(3), 111; https://doi.org/10.4414/cvm.2007.01236 (registering DOI) - 23 Mar 2007

Viewed by 12

Abstract

Drei Monate nach Implantation eines CRTGerätes hatte sich die Dyspnoe des Patienten von NYHA IV auf NYHA II verbessert [...] Full article

3 pages, 234 KB

Open AccessCase Report

Nichtkardiogenes Kontrastmittelinduziertes Lungenödem

by Christophe A. Wyss and Thomas F. Lüscher

Cardiovasc. Med. 2007, 10(3), 108; https://doi.org/10.4414/cvm.2007.01235 - 23 Mar 2007

Viewed by 8

Abstract

Allgemeine milde Reaktionen auf nichtionische Kontrastmittel sind häufig, schwere Reaktionen (z.B. Dyspnoe, Hypotonie, Kreislaufstillstand) sind selten [...] Full article

7 pages, 974 KB

Open AccessProceeding Paper

Endobronchiales Stenting

by Felix J. F. Herth and Ralf Eberhardt

Cardiovasc. Med. 2007, 10(3), 101; https://doi.org/10.4414/cvm.2007.01232 - 23 Mar 2007

Viewed by 10

Abstract

Patients with lung cancer often have bulky endobronchial disease, endobronchial extension, or airway compression. Many endobronchial treatment modalities are available to supplement traditional therapies for advanced lung cancer. Since the early 1980s, technical advances in interventional techniques have enhanced symptom-free survival and quality of life for patients with lung cancer. Although interventional procedures are not definitive therapies, they often relieve the strangling sensation produced by airway occlusion. For patients with respiratory symptoms associated with their disease, the stent placement provides symptom palliation and improves quality of life. The author reviews the use of several available endobronchial stents. Full article

Journal Menu

Journal Browser

Cardiovasc. Med., Volume 10, Issue 3 (03 2007) – 6 articles

Further Information

Guidelines

MDPI Initiatives

Follow MDPI